NCT00003498 2021-01-22
Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
Burzynski Research Institute
Phase 2 Terminated
Clinical Trials
5 trialsNCT00003499 2020-11-24
Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
Burzynski Research Institute
Phase 2 Completed
NCT00003500 2018-02-05
Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003501 2018-02-05
Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003502 2013-07-10
Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Withdrawn